TerrAscend (OTCMKTS:TSNDF) Stock Rating Lowered by Atb Cap Markets

TerrAscend (OTCMKTS:TSNDFGet Free Report) was downgraded by equities research analysts at Atb Cap Markets from a “strong-buy” rating to a “hold” rating in a research report issued on Monday,Zacks.com reports.

TerrAscend Stock Performance

OTCMKTS:TSNDF opened at $0.75 on Monday. The company has a debt-to-equity ratio of 0.81, a quick ratio of 0.69 and a current ratio of 1.35. TerrAscend has a 12-month low of $0.66 and a 12-month high of $2.45. The stock’s 50 day moving average price is $0.99 and its two-hundred day moving average price is $1.23.

About TerrAscend

(Get Free Report)

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names.

Read More

Receive News & Ratings for TerrAscend Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TerrAscend and related companies with MarketBeat.com's FREE daily email newsletter.